4.6 Article

Pregnant women's perceptions of the COVID-19 vaccine: A French survey

Journal

PLOS ONE
Volume 17, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0263512

Keywords

-

Ask authors/readers for more resources

This study evaluated pregnant women's perceptions and acceptance of COVID-19 vaccination. The results showed that about one-third of pregnant women were willing to receive the vaccine, with the main reason for refusal being concerns about potential side effects on the fetus. Factors influencing acceptance included age, multiparity, discussion with healthcare providers, and acceptance of the influenza vaccine.
Introduction Pregnant women are at increased risk for COVID-19, and COVID-19 vaccine is the most promising solution to overcome the current pandemic. This study was conducted to evaluate pregnant women's perceptions and acceptance of COVID-19 vaccination. Materials & methods A cross-sectional study was conducted from February 18 to April 5 2021. An anonymous survey was distributed in 7 French obstetrics departments to all pregnant women before a prenatal visit. All pregnant women attending a follow-up consultation were asked to participate in the study. An anonymous web survey was available through a QR code and participants were asked whether or not they would agree to be vaccinated against SARS-CoV-2, and why. The questionnaire included questions on the patients' demographics and their knowledge of COVID-19 vaccines. Results Of the 664 pregnant women who completed the questionnaire, 29.5% (95% CI 27.7; 31.3) indicated they would agree to be vaccinated against COVID-19. The main reason for not agreeing was being more afraid of potential side effects of the SARS-CoV-2 vaccine on the fetus than of COVID-19. Factors influencing acceptance of vaccination were: being slightly older, multiparity, having discussed it with a caregiver and acceptance of the influenza vaccine. Discussion Nearly one-third of pregnant women in this population would be willing to be vaccinated. In addition to studies establishing fetal safety, public health agencies and healthcare professionals should provide accurate information about the safety of COVID-19 vaccines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Acoustics

New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus

C. Egloff, J. Sibiude, C. Vauloup-Fellous, A. Benachi, E. Bouthry, F. Biquard, A. Hawkins-Villarreal, N. Houhou-Fidouh, L. Mandelbrot, A. J. Vivanti, O. Picone

Summary: This study evaluated the efficacy and safety of valacyclovir (VCV) treatment in preventing maternal-fetal transmission of congenital cytomegalovirus (CMV) infection. The results showed that VCV treatment was significantly associated with a reduction in maternal-fetal CMV transmission rate. The treatment may be particularly effective for primary infections in the first and second trimesters.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2023)

Editorial Material Pediatrics

Medical and neurodevelopmental outcomes at 10 months of age in infants born at 34 weeks plus to mothers with COVID-19

Antoine Martenot, Imad Labbassi, Amelie Delfils-Stern, Philippe Deruelle, Pierre Kuhn

ACTA PAEDIATRICA (2023)

Article Immunology

Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery

Jeanne Sibiude, Jerome Le Chenadec, Laurent Mandelbrot, Alexandre Hoctin, Catherine Dollfus, Albert Faye, Eida Bui, Emmanuelle Pannier, Jade Ghosn, Valerie Garrait, Veronique Avettand-Fenoel, Pierre Frange, Josiane Warszawski, Roland Tubiana

Summary: Antiretroviral therapy initiated before pregnancy and continued throughout pregnancy can significantly reduce perinatal transmission of HIV. Factors such as not breastfeeding, infant prophylaxis, and maternal viral suppression near delivery play important roles in preventing transmission.

CLINICAL INFECTIOUS DISEASES (2023)

Review Obstetrics & Gynecology

Systematic review and synthesis of stillbirths and late miscarriages following SARS-CoV-2 infections

Noemi Alcover, Giulia Regiroli, Alexandra Benachi, Christelle Vauloup-Fellous, Alexandre J. Vivanti, Daniele De Luca

Summary: This study aimed to describe the characteristics of fetal demise after SARS-CoV-2 infections. The results showed that fetal demise generally occurs a few days after the infection and is associated with placental inflammatory lesions and placental insufficiency.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Letter Obstetrics & Gynecology

Whole-exome sequencing and hyperemesis gravidarum: Is there a role of hCG?

Philippe Deruelle, Audrey Tranchant

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

Development of placental lesions after recovery from COVID-19 during pregnancy: case-control study

C. Milot, A. Koch, G. Averous, S. Mayeur, P. Deruelle

Summary: This study aims to explore whether the occurrence and type of placental lesions vary according to the time of onset of COVID-19 in pregnant women. The results showed that the COVID-19 group had a higher rate of vascular complications, fetal and maternal vascular malperfusion, and signs of inflammation compared to the control group. Moreover, the occurrence of chronic villitis differed between the COVID-19 group that delivered within 14 days after infection and the group that delivered more than 14 days after infection.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Virology

Impact of SARS-CoV-2 Infection on Unvaccinated Pregnant Women: Non-Reassuring Fetal Heart Rate Tracing Because of Placentitis

Alexandra Claudet, Daniele De Luca, Elie Mosnino, Jeremie Mattern, Olivier Picone, Jeanne Sibiude, Estelle Wafo, Vassilis Tsatsaris, Emilie Giral, Irene Grefenstette, Julie Carrara, Dominique A. Badr, Marie-Helene Saint-Frison, Sophie Prevot, Alexandra Benachi, Alexandre J. Vivanti

Summary: In 2020, a new coronavirus called SARS-CoV-2 emerged in China and has been shown to cause severe illness in pregnant women, leading to increased maternal and neonatal mortality. Some studies have found maternal-fetal transmission and placental abnormalities in SARS-CoV-2-infected mothers. This study aims to identify the determinants associated with non-reassuring fetal heart rate in these cases. Retrospective analysis of data from 17 infected mothers and their fetuses revealed a high incidence of maternal coagulopathy, iatrogenic prematurity, and placental insufficiency. The findings suggest that SARS-CoV-2 infection during pregnancy can result in neonatal morbidity due to placental damage.

VIRUSES-BASEL (2023)

Article Immunology

Spatio-temporal changes in pre-exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation

Haoyi Wang, Jean-Michel Molina, Rosemary Dray-Spira, Axel J. Schmidt, Ford Hickson, David van de Vijver, Kai J. Jonas

Summary: This study used national pharmaco-epidemiology surveillance data and regional MSM population estimations to model the spatio-temporal distribution of PrEP uptake among MSM in France 2016-2021 to identify marginalized MSM at risk for HIV and increase their PrEP uptake.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Multidisciplinary Sciences

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

Henrieke A. B. Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J. Overmars, Grigorius Papageorgiou, Yvonne M. Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J. A. Rijnders, Hannelore I. Bax, Eric C. M. van Gorp, Jan L. Nouwen, Theodora E. M. S. de, Carolina A. M. Schurink, Mariana de Mendonca Melo, Els van Nood, Angela Colbers, David Burger, Robert-Jan Palstra, Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Thibault Mesplede, Peter D. Katsikis, Rob A. Gruters, Birgit C. P. Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx

Summary: The BAF complex inhibitor pyrimethamine can reactivate the latent HIV-1 reservoir in people living with HIV-1 (PLWH) on suppressive antiretroviral therapy, but does not lead to a reduction in the size of the inducible reservoir.

SCIENCE ADVANCES (2023)

Article Medicine, General & Internal

Risk Factors for Anal Continence Impairment Following a Second Delivery after a First Traumatic Delivery: A Prospective Cohort Study

Gabriel Marcellier, Axelle Dupont, Agnes Bourgeois-Moine, Arnaud Le Tohic, Celine De Carne-Carnavalet, Olivier Poujade, Guillaume Girard, Amelie Benbara, Laurent Mandelbrot, Laurent Abramowitz

Summary: Postpartum anal incontinence is common. Follow-up is advised after a first delivery with perineal trauma to reduce the risk of anal incontinence. Endoanal sonography may be considered to evaluate the sphincter and discuss cesarean section for the second delivery. Risk factors for anal continence impairment after the second delivery were the presence of urinary incontinence and the combined use of instruments and episiotomy. Sphincter rupture diagnosed through endoanal sonography was not associated with continence impairment after the second delivery.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Obstetrics & Gynecology

Nasopharyngeal SARS-CoV-2 load and perinatal outcomes after maternal infection diagnosed close to delivery

Alexandre J. Vivanti, Christelle Vauloup-Fellous, Asma Khalil, Dominique A. Badr, Francesco Raimondi, Serena Salome, Smriti Prasad, Giuseppe Portella, Mariano Fiorenza, Jacques C. Jani, Luce Landraud, Olivier Picone, Lucilla Pezza, Nadege Bourgeois-Nicolaos, Anne-Gael Cordier, Luca Vedovelli, Daniele De Luca

Summary: This study investigated the relationship between nasopharyngeal viral load and perinatal outcomes in pregnant women diagnosed with COVID-19 in the third trimester. The results showed no significant association between maternal nasopharyngeal viral load and outcomes such as preterm birth and low birth weight.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2023)

Article Obstetrics & Gynecology

Management and survival of foetuses with trisomy 18 in a French retrospective cohort

Ana Bouzaglou, Gregoire Dumery, Alexandra Letourneau, Alexandra Benachi, Alexandre J. Vivanti, Anne-Gael Cordier

Summary: The study aimed to evaluate parents' demands after the diagnosis of trisomy 18 and maternal risks. A retrospective study was conducted in a fetal medicine department in Paris from 2018 to 2021. The results showed that the majority of patients chose medical termination of pregnancy, while a minority opted to continue with significant obstetrical complications.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2023)

Letter Obstetrics & Gynecology

SARS-COV-2 excretion and maternal-fetal transmission: Virological data of French prospective multi-center cohort study COVIPREG during the first wave

Olivier Picone, Alexandre J. Vivanti, Jeanne Sibiude, Anne-Gael Cordier, Vivien Alessandrini, Gilles Kayem, Constance Borie, Dominique Luton, Pauline Manchon, Camille Couffignal, Christelle Vauloup Fellous

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2023)

Article Multidisciplinary Sciences

Characteristics and short- and long-term direct medical costs among adults with timely and delayed presentation for HIV care in the Netherlands

Stephanie Popping, Lisbeth E. Versteegh, Brooke Nichols, David A. M. C. van de Vijver, Ard van Sighem, Peter Reiss, Suzanne Geerlings, Charles A. B. Boucher, Annelies Verbon

Summary: In Europe, many people living with HIV (PLWH) are diagnosed and start treatment late, leading to worse health outcomes. This study analyzed data from the ATHENA cohort in the Netherlands to assess the costs of HIV-care based on time of presentation and identify factors contributing to higher costs in the first and fifth year of antiretroviral therapy (ART) initiation. The study found that very late presentation was associated with substantial costs, particularly non-ART medication costs, which were nearly seven times higher compared to timely presentation.

PLOS ONE (2023)

Article Obstetrics & Gynecology

Prenatal diagnosis of isolated bilateral clubfoot: Is amniocentesis indicated?

Edouard Leyne, Olivia Anselem, Penelope Jordan, Alexandre J. Vivanti, Alexandra Benachi, Laurent Salomon, Mathilde Jacquier, Jean-Marie Jouannic, Ferdinand Dhombres, Tatiana Cambier, Jonathan Rosenblatt, Emmanuelle Pannier, Francois Goffinet, Vassilis Tsatsaris, Yoann Athiel

Summary: This study evaluated the benefit of cytogenetic testing by amniocentesis for isolated bilateral talipes equinovarus diagnosed by ultrasound. Despite the low rate of pathogenic chromosomal abnormalities diagnosed prenatally, the risk of chromosomal aberration still exceeds the risks of amniocentesis.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

No Data Available